The first batch of 60,000 doses of the Johnson & Johnson Covid-19 vaccine arrived Wednesday in Romania.
It becomes the fourth vaccine to be approved for use in Romania in its rollout which began in late December.
However, it won’t be used immediately in the vaccine campaign following reports of a “rare but severe” blood clot reported in some individuals after getting a shot.
The vaccines arrived early in the morning and will initially be placed in storage, authorities said Wednesday.
Vaccine coordinator Valeriu Gheorhgita said Tuesday he was waiting for the European Medicines Agency to issue guidelines regarding possible links between the vaccine and blood clots.
So far, some 2.37 million people have received at least one Covid-19 shot in Romania, while more than 3.83 million doses have been administered.
Romania is currently using the Pfizer-BioNTech, Moderna, and AstraZeneca vaccines.
Johnson & Jonhson differs from the other vaccines as it’s a single-dose shot.
Dr. Gheorghita, said Tuesday that Johnson & Johnson doses will also be used to vaccinate Romanian prisoners.
Prisoners will get their jabs from medical staff at the facilities. Heath professionals outside the system will be allowed to administer doses, but only in exceptional cases, he said.
The United States Center for Disease Control and Food and Drug Administration on Tuesday recommended a pause in the use of the vaccine pending a review of data involving six reported US cases of “a rare and severe type of blood clot in individuals” after getting the vaccine.
Johnson & Johnson also announced that it would “proactively delay the rollout of our vaccine in Europe and pause vaccinations in all Janssen Covid-19 vaccine clinical trials while we update guidance for investigators and participants.”